CLND Fails to Improve Melanoma Survival Rates
|
By HospiMedica International staff writers Posted on 19 Jun 2017 |
A new study shows that immediate completion lymph-node dissection (CLND) does not increase survival among patients with melanoma and sentinel-node metastases.
Researchers at the John Wayne Cancer Institute (JWCI; Santa Monica, CA, USA), Sentara CarePlex Hospital (Hampton, VA, USA), and other institutions worldwide conducted a study that randomly assigned 1,934 patients with sentinel-node metastases--detected via standard pathological assessment or a multimarker molecular assay--to immediate CLND or to an observation group monitored with ultrasonography. Main outcomes and measures were melanoma-specific survival, disease-free survival, and cumulative rate of non-sentinel-node metastasis.
The results showed that Immediate CLND was not associated with increased melanoma-specific survival. In the per-protocol analysis, the mean three-year rate of melanoma-specific survival was similar in the dissection group and the observation group (86%) at a median follow-up of 43 months. The mean rate of disease-free survival was slightly higher in the dissection group (68%) than in the observation group (63%) at three years. Lymphedema was observed in 24.1% of the patients in the dissection group and in 6.3% of those in the observation group. The study was published on June 8, 2017, in the New England Journal of Medicine (NEJM).
“Although the completion dissections did not help overall survival, they did have some value. By examining the dissected lymph nodes, physicians were able to better gauge how extensively the cancer had spread and to lengthen the time that their patients were disease-free. But those advantages did not translate into longer lives,” said lead author Mark Faries, MD, of JWCI. “The new findings likely will result in many fewer of these procedures being performed around the world. The results also will likely affect the design of many current and future clinical trials of medical therapies in melanoma.”
Lymph nodes, located throughout the body, serve as biologic filters that contain immune cells that fight infection and clean the blood. When cancer cells break away from a tumor, the cells can travel through the lymph system; sentinel node surgery allows the surgeon to remove the nodes to determine cancer spread. As human nodes are only 5 mm in size, they are difficult to discern from the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether or not the lymph nodes contain cancer, requiring removal of more lymph nodes than necessary.
Related Links:
John Wayne Cancer Institute
Sentara CarePlex Hospital
Researchers at the John Wayne Cancer Institute (JWCI; Santa Monica, CA, USA), Sentara CarePlex Hospital (Hampton, VA, USA), and other institutions worldwide conducted a study that randomly assigned 1,934 patients with sentinel-node metastases--detected via standard pathological assessment or a multimarker molecular assay--to immediate CLND or to an observation group monitored with ultrasonography. Main outcomes and measures were melanoma-specific survival, disease-free survival, and cumulative rate of non-sentinel-node metastasis.
The results showed that Immediate CLND was not associated with increased melanoma-specific survival. In the per-protocol analysis, the mean three-year rate of melanoma-specific survival was similar in the dissection group and the observation group (86%) at a median follow-up of 43 months. The mean rate of disease-free survival was slightly higher in the dissection group (68%) than in the observation group (63%) at three years. Lymphedema was observed in 24.1% of the patients in the dissection group and in 6.3% of those in the observation group. The study was published on June 8, 2017, in the New England Journal of Medicine (NEJM).
“Although the completion dissections did not help overall survival, they did have some value. By examining the dissected lymph nodes, physicians were able to better gauge how extensively the cancer had spread and to lengthen the time that their patients were disease-free. But those advantages did not translate into longer lives,” said lead author Mark Faries, MD, of JWCI. “The new findings likely will result in many fewer of these procedures being performed around the world. The results also will likely affect the design of many current and future clinical trials of medical therapies in melanoma.”
Lymph nodes, located throughout the body, serve as biologic filters that contain immune cells that fight infection and clean the blood. When cancer cells break away from a tumor, the cells can travel through the lymph system; sentinel node surgery allows the surgeon to remove the nodes to determine cancer spread. As human nodes are only 5 mm in size, they are difficult to discern from the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether or not the lymph nodes contain cancer, requiring removal of more lymph nodes than necessary.
Related Links:
John Wayne Cancer Institute
Sentara CarePlex Hospital
Latest Surgical Techniques News
- Fluorescence Imaging Reveals Nerves Under Normal Operating-Room Lighting
- Programmable Microwave Ablation System Gains CE Mark for Minimally Invasive Tissue Ablation
- Researchers Develop Microbots to Help Drugs Reach Blood Clots
- Minimally Invasive Balloon Procedure May Redirect Blood Flow During Cardiac Arrest
- First Stemless Reverse Shoulder Arthroplasty System Receives FDA Clearance in U.S.
- First U.S. Procedures Successfully Completed With New GERD Implant
- Study Explores 4DCT Ventilation for Preoperative Assessment in Early Lung Cancer
- Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
- FDA Approves First Transcatheter Device for Paravalvular Leak Closure
- Smaller Surgical Margins May Help Protect Healthy Tissue in Young Sarcoma Patients
- BD Launches TIPS Stent Graft for Personalized Portal Hypertension Treatment
- Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma
- FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

- Miniature Image Sensor Enables Digital Imaging in Single-Use Endoscopes
- Transcatheter Repair System Gains FDA Approval for Severe Tricuspid Regurgitation
- Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia
Channels
Artificial Intelligence
view channel
AI Analysis of Smartwatch ECGs May Help Detect Weakened Heart Function
Left ventricular systolic dysfunction (LVSD) occurs when the heart’s main pumping chamber does not contract effectively. The condition can remain asymptomatic for some time but may progress to symptomatic... Read more
AI Tool Speeds Echocardiogram Reporting With Comparable Accuracy
Echocardiography is the most widely used form of cardiac imaging, playing a key role in diagnosing heart disease and guiding treatment decisions. However, reviewing ultrasound images and documenting cardiac... Read moreCritical Care
view channel
Inhaled Therapy Uses Modified Bacteria to Break Down Pseudomonas Biofilms
Biofilms are protective layers of bacteria that can form inside endotracheal tubes during mechanical ventilation, making infections difficult to treat because intravenous antibiotics often struggle to... Read more
Miniature Wearable Sensor Enables Continuous Cuffless Blood Pressure Monitoring
Blood pressure is a key indicator of cardiovascular health, but conventional cuff-based measurement typically provides only a single reading at one point in time. This can limit monitoring during everyday... Read morePatient Care
view channelVirtual Reality Program May Reduce Anxiety Before Pediatric Surgery
Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read moreMedical Imaging
view channel
Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis
Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more
MRI Test Identifies Candidates for Lower-Dose Radiotherapy in HPV Throat Cancer
Human papillomavirus (HPV)-positive oropharyngeal cancer is a throat cancer linked to HPV infection. Its incidence is rising, and many patients receive high-dose radiotherapy that can cause long-term swallowing... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read morePoint of Care
view channel
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read moreBusiness
view channel
Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings
Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more







